(Q40991549)

25 September 2017

title

Acebutolol in hypertension: Relationships between drug concentration and effects (English)

1 reference

9 April 2023

1 reference

9 April 2023

author name string

M. A. Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367793

9 April 2023

F. C. Phillips

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367793

9 April 2023

G. T. Tucker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367793

9 April 2023

A. J. Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367793

9 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367793

9 April 2023

publication date

1 December 1978

1 reference

25 September 2017

18 December 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367793

full work available at URL

9 April 2023

http://link.springer.com/content/pdf/10.1007/BF00716378.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00716378/fulltext.html

9 April 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00716378

9 April 2023

1 reference

European Journal of Clinical Pharmacology

9 April 2023

published in

1 reference

25 September 2017

volume

14

1 reference

25 September 2017

issue

6

1 reference

25 September 2017

page(s)

383-390

1 reference

Suppression of premature ventricular contractions by acebutolol

25 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00716378

Acebutolol in hypertension-double-blind trial against placebo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00716378

Acebutolol metabolite plasma concentration during chronic oral therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00716378

Controlled trial of acebutolol in hypertension

21 January 2018

1 reference

12 December 2020

Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man

1 reference

12 December 2020

Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol

1 reference

12 December 2020

Beta-blockers and plasma renin activity in hypertension.

1 reference

12 December 2020

Anti-hypertensive effect of acebutolol: its relation to sympathetic nervous system responsiveness and to plasma renin and dopamine-beta-hydroxylase activities

1 reference

12 December 2020

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

1 reference

12 December 2020

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

12 December 2020

Effect of active drug metabolites on plasma level-response correlations

1 reference

12 December 2020

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity

1 reference

12 December 2020

Accurate and rapid measurement of plasma renin activity by radioimmunoassay. Results in normal and hypertensive people

1 reference

12 December 2020

Acebutolol disposition after intravenous administration.

1 reference

12 December 2020

High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite

1 reference

12 December 2020

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients

1 reference

12 December 2020

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker)

1 reference

12 December 2020

The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels

1 reference

12 December 2020

Why another beta-antagonist?

1 reference

12 December 2020

The variability of arterial pressure

1 reference

12 December 2020

Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses

1 reference

12 December 2020

Pharmacokinetics of propranolol: a review

1 reference

12 December 2020

Why hypertensive patients vary in their response to oral debrisoquine

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00716378

1 reference

25 September 2017

1 reference